Table 1.
Disease Model | How comprehensive is the body of sleep/circadian research in this model? | Does this model reflect human PD-related circadian rhythm changes? | Does this model reflect human PD-related sleep dysfunction? | References |
---|---|---|---|---|
6-OHDA | *** | ++ | +++ | [18–36] |
MPTP | *** | -- | --- | [37–46] |
Rotenone | ** | + | + | [47–53] |
α-Synuclein Transgenic | ** | ++ | +++ | [54–59] |
LRRK-G2019S Transgenic | * | N/A | + | [60] |
VMAT2-deficient | * | - | -- | [61, 62] |
MitoPark | * | +++ | +++ | [63, 64] |
Cycad | * | + | N/A | [65] |
Paraquat/Maneb | N/A | N/A | N/A | –––– |
PFF | N/A | N/A | N/A | –––– |
Other Transgenic models (i.e. DJ-1, PINK) | N/A | N/A | N/A | –––– |
Table 1: Evidence is indicated by – and +, with --- being compelling evidence for a lack of a PD-like phenotype, +++ being compelling evidence of a PD-like phenotype, comprehensiveness of the body of research indicated by asterisks, where *** is very comprehensive, ** requires further studies to corroborate and further confirm, * a very limited number of studies have been relied upon to arrive at the particular conclusion, N/A where no studies have been performed